HGF Presents

HGF Presents is an exclusive series of concise, high-quality videos. This carefully curated series provides essential insights into a range of topics in EP law and practice, designed to keep you informed and ahead of the curve. Our specialists in each field will guide you through the key legal issues, highlight potential pitfalls and provide practical advice, helping you to navigate the complexities of EP law.

Series covers Patentability of AI Inventions at the EPO, Diagnostic Methods, Unclear Claim Parameters, and Undisclosed Disclaimers.

Series covers Claiming Priority, Regulatory Exclusivity for Medicinal Products in Europe, Bioinformatics at the EPO and an Overview of Oppositions & Appeals at the EPO.

Series covers SPCs in Europe, Unitary Patent, Description Amendment Requirements at the EPO and Computer Implemented Inventions.

Series 4 covers Patenting Polymorphs at the EPO, Added Matter 1 & 2 and Antibodies.

These videos are available for download, allowing you to review them at your convenience.

For more information and to see our recent legal updates please click here.

Series 1, 2, 3 & 4 are all available to download now

Available now for Series 1:

  • Patentability of AI Inventions at the EPO
  • Diagnostic Methods
  • Unclear Claim Parameters
  • Undisclosed Disclaimers

 

Available now for Series 3:

  • Supplementary Protection Certificates (SPCs) in Europe
  • Unitary Patent
  • Description Amendment Requirements at the EPO
  • Computer Implemented Inventions

Available now for Series 2:

  • Overview of Oppositions and Appeals at the EPO
  • Regulatory Exclusivity for Medical Products in Europe
  • Priority
  • Bioinformatics

 

Available now for Series 4:

  • Patenting Polymorphs at the EPO
  • Added Matter – Part 1
  • Added Matter – Part 2
  • Antibodies

Latest legal updates

MevoCem Nominated for the Earthshot Prize by CIPA

We’re delighted to share that our client, Material Evolution, has been nominated by the Chartered Institute of Patent Attorneys (CIPA) for the globally renowned Earthshot Prize, in recognition of their …

Read article

HGF Sets the Gold Standard – Recognised for 7th Year in a Row by Financial Times

We are extremely honoured to announce that HGF has once again been ranked ‘Gold’ across all six bands in the Financial Times Special Report – Europe’s Leading Patent Law Firms …

Read article

UPC delivers first judgment on Validity and Infringement of a Second Medical Use Claim

Sanofi Biotechnology SAS & Anor v Amgen, Inc., & Ors– Thomas, Thom, Kupecz and Dorland-Galliot – [UPC_CFI_505/2024] The Dusseldorf Local Division (LD) has delivered the UPC’s first Judgment on second …

Read article

The Strawberry Patent Battle: Seeds, Speculation, and Jurisdiction

  This case, relating to infringement of a US plant patent, deals with the evidentiary burden required to show infringement of a plant patent in the US, as well as …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article

T1977/22: Can claims defined by open-ended ranges ever be sufficiently disclosed?

The EPO’s Board of Appeal’s decision in T1977/22 provides an interesting review of the case law concerning the compatibility of whole range sufficiency and claims defined as a result to …

Read article

The draft of The Genetic Technology (Precision Breeding) Regulations 2025 reveals practical details on how to obtain a Precision Bred Organism status

In a recent blog post we discussed the Precision Breeding Regulatory Framework developed by the Food Standards Agency (FSA). Further details on the application process for Precision Bred Organism confirmation …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article